Internal Medicine Doctors in Muscatine, IA Accepting Medicare

6 Internal Medicine doctors found. Showing 1 - 6

Dr. Robert F Weis, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1518 Mulberry Ave, Muscatine, IA 52761 Phone: 563-262-4111

Dr. James Adriel Kwirant, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1518 Mulberry Ave, Muscatine, IA 52761 Phone: 563-262-4111

Manasi P Nadkarni, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1518 Mulberry Ave, Muscatine, IA 52761 Phone: 563-262-4111    Fax: 563-264-9175

Dr. Melinda A Smith, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1518 Mulberry Ave, Muscatine, IA 52761 Phone: 563-262-4111    Fax: 563-264-9175

Dr. Tuba Muhammad Ali, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1518 Mulberry Ave, Muscatine, IA 52761 Phone: 309-786-4340    Fax: 515-440-5089

Maitreyi Janarthanan, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1903 Park Ave, Suite 1500, Muscatine, IA 52761 Phone: 563-263-1903    Fax: 563-263-1904

News Archive

Study reveals a new, effective treatment for chronic insomnia

A new treatment for chronic insomnia, transcranial alternating corrent stimulation, has been found to be effective in a study published in Psychotherapy and Psychosomatics.

Miracle probiotics? Take claims with a pinch of salt, says study

A new study published in the journal Frontiers in Medicine cautions the public against believing and acting on information on probiotics online because most of the websites offering such information are not dependable and their sources are dubious

CARE Oklahoma partners with COMS Interactive

The Coalition of Advocates for Responsible Eldercare (CARE Oklahoma) has announced their newest CARE Partnership with COMS Interactive, LLC (also known as Clinical Outcomes Management Systems or COMS).

Data from FAME Phase 3 study for Iluvien presented at Angiogenesis 2010

pSivida Corp., a leader in the development of ophthalmic sustained release drug delivery products, with two of the only three such products approved by the FDA for treatment of back of the eye diseases, today said that 24-month data from the FAME Phase 3 study for Iluvien presented at Angiogenesis 2010 included additional efficacy and safety data that reinforced the positive top-line results reported in December 2009 by pSivida and its licensee, Alimera Sciences, Inc.

Partners can directly influence pregnant woman's likelihood of drinking alcohol, study finds

A new study by a team of University of Rochester psychologists and other researchers in the Collaborative Initiative on Fetal Alcohol Spectrum Disorders finds that partners of mothers-to-be can directly influence a pregnant woman's likelihood of drinking alcohol and feeling depressed, which affects their babies' development.

Read more Medical News

› Verified 3 days ago